Furthermore, functional interaction between WNT activity and PD-L1 expression underpins specific WNT activators or inhibitors to lower or enhance PD-L1 expression for the cure of triple-negative breast cancer (TNBC) [101]. The gene discussed is CD274; the disease is triple-negative breast carcinoma.